Clinical Trial Update: Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant Chemoradiotherapy [Phase 3]

View source ↗

Summary

This Phase 3 trial investigates preoperative enteral immunonutrition for esophageal cancer patients receiving neoadjuvant chemoradiotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Enteral immunonutrition

Snippet

Sponsor: Hecheng Li M.D., Ph.D | Conditions: Esophageal Neoplasms | Phase 3 | Status: RECRUITING